Healthy volunteers help Fine-Tune experimental drug vonafexor

NCT ID NCT07251153

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial is testing two forms of the experimental drug vonafexor (EYP651) in 40 healthy adults. The goal is to compare how the body processes the acid form versus the lysine salt form, and to check for interactions with other common medications. Results will guide future studies, but this trial does not test the drug's ability to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

vonafexor (EYP651)

What this could lead to

If successful, this study could help determine the best form of vonafexor for future trials and how it interacts with other drugs.

What could go wrong

This is an early Phase 1 trial in healthy volunteers, not patients. Results may not predict effects in people with the target disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE AND FEMALE VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Eurofins Optimed

    RECRUITING

    Gières, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••